Variant report
Variant | nsv528860 |
---|---|
Chromosome Location | chr10:91704812-91709123 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PANK1-7 | chr10:91705952-91706174 | NONHSAT015579 |
2 | lnc-PANK1-7 | chr10:91706886-91707110 | NONHSAT015579 |
3 | lnc-PANK1-7 | chr10:91705612-91705740 | NONHSAT015579 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1924706 | chr10:91704812-91704813 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs566157783 | chr10:91704813-91704814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs183054024 | chr10:91704819-91704820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1924707 | chr10:91704850-91704851 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs548437037 | chr10:91704931-91704932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143789851 | chr10:91704946-91704947 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568170654 | chr10:91704967-91704968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs117355878 | chr10:91704987-91704988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs556229053 | chr10:91705002-91705003 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372161143 | chr10:91705074-91705075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs146357022 | chr10:91705158-91705159 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs58848913 | chr10:91705165-91705166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs144338541 | chr10:91705189-91705190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs56703504 | chr10:91705190-91705191 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs541172223 | chr10:91705199-91705200 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs201636048 | chr10:91705241-91705242 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs397771991 | chr10:91705255-91705256 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560919366 | chr10:91705307-91705308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs77961189 | chr10:91705321-91705322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs187620381 | chr10:91705378-91705379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149426970 | chr10:91705404-91705405 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563366682 | chr10:91705544-91705545 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532339653 | chr10:91705561-91705562 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs552400159 | chr10:91705575-91705576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559752925 | chr10:91705588-91705589 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs113247670 | chr10:91705649-91705650 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs76137222 | chr10:91705684-91705685 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs548803755 | chr10:91705706-91705707 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs144801820 | chr10:91705779-91705780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs372145235 | chr10:91705786-91705787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551267273 | chr10:91705832-91705833 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs80059117 | chr10:91705836-91705837 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569682564 | chr10:91705847-91705848 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs538596075 | chr10:91705910-91705911 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148552738 | chr10:91705932-91705933 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184333699 | chr10:91705952-91705953 | Active TSS Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs187999237 | chr10:91705955-91705956 | Active TSS Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs17129349 | chr10:91705970-91705971 | Active TSS Enhancers Flanking Active TSS | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs554780017 | chr10:91705999-91706000 | Active TSS Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs35054991 | chr10:91706053-91706054 | Active TSS Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs574267388 | chr10:91706087-91706088 | Active TSS Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs142473606 | chr10:91706116-91706117 | Active TSS Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs376582021 | chr10:91706125-91706126 | Active TSS Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs77269520 | chr10:91706132-91706133 | Active TSS Enhancers Flanking Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs373637542 | chr10:91706247-91706248 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs539078467 | chr10:91706268-91706269 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192470435 | chr10:91706293-91706294 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs535786638 | chr10:91706886-91706887 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs372717682 | chr10:91706910-91706911 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs184721790 | chr10:91706919-91706920 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Lung cancer | 18438408 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Usher syndrome | 20538994 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Paraganglioma | 17535989 | CNVD |
Submicroscopic aberration syndrome | 21292638 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Colorectal cancer | 18645599 | CNVD |
Polyposis syndrome | 18645599 | CNVD |
Prostate cancer | 17245344 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 22032731 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Wilms tumour | 21544195 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neurocytoma | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Basal-like breast cancer | 18066063 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Lung cancer | 21911935 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 22048815 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 21049055 | CNVD |
Cervical cancer | 21062161 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 24453001 | CNVD |
Breast cancer | 16608533 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:91700200-91705600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr10:91704600-91705000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr10:91705000-91706000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
4 | chr10:91705200-91706000 | Enhancers | Primary T helper naive cells fromperipheralblood | blood |
5 | chr10:91705200-91706200 | Enhancers | Primary T helper cells fromperipheralblood | blood |
6 | chr10:91705400-91706000 | Enhancers | Primary B cells from peripheral blood | blood |
7 | chr10:91705400-91706000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr10:91705400-91706400 | Enhancers | Primary T helper memory cells from peripheral blood 2 | blood |
9 | chr10:91705600-91706000 | Enhancers | Primary T cells effector/memory enriched fromperipheralblood | blood |
10 | chr10:91705800-91706200 | Enhancers | Primary T cells from cord blood | blood |
11 | chr10:91705800-91706200 | Enhancers | Primary T helper cells PMA-I stimulated | -- |
12 | chr10:91705800-91706200 | Flanking Active TSS | Dnd41 | blood |
13 | chr10:91705800-91706200 | Active TSS | NHDF-Ad | bronchial |
14 | chr10:91705800-91706200 | Active TSS | NHLF | lung |
15 | chr10:91705800-91706400 | Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
16 | chr10:91706200-91706400 | Enhancers | Dnd41 | blood |
17 | chr10:91708600-91710200 | Enhancers | Fetal Brain Male | brain |